Skip to content
HowShorted

Viridian Therapeutics, Inc.\DE short interest in 2026

In 2026, Viridian Therapeutics, Inc.\DE's disclosed short interest ran from 8.54% of shares outstanding on 15 Jan 2026 to 17.18% on 15 Sep 2026, a change of +8.64 percentage points. The year's high was 18.66% on 31 Jul 2026 and its low 8.13% on 13 Feb 2026, averaging 13.18% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.55 days on 31 Aug 2026. Full history: Viridian Therapeutics, Inc.\DE.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Viridian Therapeutics, Inc.\DE in 2026

2026 in figures

Start of year
8.54% (15 Jan 2026)
End of year
17.18% (15 Sep 2026)
Change
+8.64 pp
High
18.66% (31 Jul 2026)
Low
8.13% (13 Feb 2026)
Average
13.18%
Highest days to cover
16.55 (31 Aug 2026)
SEC filings marked
6

Every report in 2026

Viridian Therapeutics, Inc.\DE short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 20268.54%5.20
30 Jan 20268.32%5.38
13 Feb 20268.13%5.55
27 Feb 20268.19%5.9610-K filed, results (8-K)
13 Mar 20268.63%7.27
31 Mar 202611.36%3.96
15 Apr 202611.16%2.59
30 Apr 202612.06%6.90
15 May 202613.84%3.0610-Q filed, results (8-K)
29 May 202614.16%7.89
15 Jun 202614.57%10.09
30 Jun 202616.83%5.56
15 Jul 202618.36%9.87
31 Jul 202618.66%11.31
14 Aug 202616.79%9.0510-Q filed, results (8-K)
31 Aug 202617.22%16.55
15 Sep 202617.18%15.74

See also: Viridian Therapeutics, Inc.\DE's full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.